tiprankstipranks
Trending News
More News >
Can-Fite BioPharma Ltd. (IL:CANF)
:CANF
Israel Market
Advertisement

Can Fite Bio (CANF) Income Statement

Compare
0 Followers

Can Fite Bio Income Statement

Last quarter (Q4 2023), Can Fite Bio's total revenue was $155.00K, a decrease of -21.32% from the same quarter last year. In Q4, Can Fite Bio's net income was $-1.65M. See Can Fite Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Gross Profit
$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Operating Expenses
$ 8.80M$ 8.94M$ 10.91M$ 13.70M$ 14.90M
Depreciation and Amortization
$ 7.00K$ 15.00K$ 14.00K$ 14.00K$ 12.00K
EBITDA
$ -8.12M$ -8.18M$ -10.08M$ -12.83M$ -14.13M
Operating Income
$ -8.13M$ -8.20M$ -10.10M$ -12.84M$ -14.14M
Other Income/Expenses
$ 250.00K$ 561.00K$ -77.00K$ 227.00K$ -304.00K
Pretax Income
$ -7.88M$ -7.63M$ -10.17M$ -12.62M$ -14.44M
Net Income
$ -7.88M$ -7.63M$ -10.53M$ -12.60M$ -14.81M
Per Share Metrics
Basic EPS
$ 0.00$ -0.01$ -0.01$ -0.03$ -0.04
Diluted EPS
$ 0.00$ -0.01$ -0.01$ -0.03$ -0.04
Weighted Average Shares Outstanding
2.18B 1.28B 815.80M 458.88M 341.51M
Weighted Average Shares Outstanding (Diluted)
2.18B 1.28B 815.75M 553.08M 358.41M
Currency in USD

Can Fite Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis